| mRNA |
Rapamycin |
CTRPv2 |
pan-cancer |
AAC |
0.0047 |
0.9 |
| mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0049 |
0.9 |
| mRNA |
ML312 |
CTRPv2 |
pan-cancer |
AAC |
-0.0093 |
0.9 |
| mRNA |
bafilomycin A1 |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.9 |
| mRNA |
ML311 |
CTRPv2 |
pan-cancer |
AAC |
0.0042 |
0.9 |
| mRNA |
JQ-1 |
CTRPv2 |
pan-cancer |
AAC |
0.004 |
0.9 |
| mRNA |
CBB-1007 |
CTRPv2 |
pan-cancer |
AAC |
0.0068 |
0.9 |
| mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0046 |
0.9 |
| mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0039 |
0.9 |
| mRNA |
SKI-II |
CTRPv2 |
pan-cancer |
AAC |
-0.0042 |
0.9 |